Schonfeld Strategic Advisors’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,000
Closed -$397K 3265
2022
Q3
$397K Sell
40,000
-6,080
-13% -$60.1K ﹤0.01% 1914
2022
Q2
$453K Buy
46,080
+10,512
+30% +$103K ﹤0.01% 1418
2022
Q1
$349K Sell
35,568
-15
-0% -$147 ﹤0.01% 1592
2021
Q4
$347K Hold
35,583
﹤0.01% 1449
2021
Q3
$347K Buy
35,583
+682
+2% +$6.6K ﹤0.01% 1453
2021
Q2
$338K Buy
+34,901
New +$339K ﹤0.01% 1403

Schonfeld Strategic Advisors's HCAR Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 40,000 shares — an estimated $397K sold.

Schonfeld Strategic Advisors first reported a position in HCAR in Q2 2021 and held it in 6 quarters. The position peaked at $453K in Q2 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 40,000 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $397K.
  • Schonfeld Strategic Advisors first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $453K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.